| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.30M | 11.00M | 6.19M | 6.42M | 14.02M | 1.29M |
| Gross Profit | 13.64M | 4.01M | 6.19M | 1.48M | 14.23M | 1.74M |
| EBITDA | 3.25M | -324.97K | -13.83M | -25.97M | 5.33M | -4.05M |
| Net Income | -7.41M | -7.32M | -15.94M | -29.24M | 4.76M | -4.04M |
Balance Sheet | ||||||
| Total Assets | 60.16M | 44.05M | 37.71M | 53.19M | 62.10M | 12.32M |
| Cash, Cash Equivalents and Short-Term Investments | 11.71M | 3.41M | 5.84M | 5.13M | 37.23M | 11.55M |
| Total Debt | 8.62M | 7.70M | 763.75K | 746.00K | 182.69K | 453.69K |
| Total Liabilities | 11.75M | 8.70M | 2.85M | 2.39M | 1.09M | 849.12K |
| Stockholders Equity | 50.14M | 37.03M | 36.19M | 49.19M | 60.76M | 11.46M |
Cash Flow | ||||||
| Free Cash Flow | -13.69M | -13.68M | -5.03M | -24.79M | -14.72M | -3.52M |
| Operating Cash Flow | -12.02M | -11.95M | -3.40M | -9.14M | 3.49M | -3.52M |
| Investing Cash Flow | -20.27M | 379.42K | 2.30M | -18.89M | -23.96M | 1.45M |
| Financing Cash Flow | 26.67M | 12.54M | -731.03K | -299.03K | 41.48M | 12.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
48 Neutral | $161.98M | -3.51 | -20.35% | ― | -19.68% | -1055.59% | |
46 Neutral | $4.89M | -0.06 | ― | ― | -12.05% | -87.87% | |
45 Neutral | $24.38M | -9.07 | -5.49% | ― | -1.30% | 81.87% | |
44 Neutral | $15.53M | -9.41 | ― | ― | 9.45% | 71.81% | |
42 Neutral | $6.60M | -0.20 | -17.58% | ― | -35.26% | 53.23% | |
41 Neutral | $5.75M | -3.16 | -16.36% | ― | -26.60% | 15.28% |
On January 7, 2026, LM Funding America disclosed that it had received a notice from Nasdaq stating the company was no longer in compliance with the exchange’s $1.00 minimum bid price requirement, after its shares closed below that level for 35 consecutive business days through January 6, 2026. The notification does not immediately affect the listing of LM Funding’s common stock, and the company has until July 6, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days, with the potential for an additional 180‑day extension or a hearing process if needed; management said it will monitor the share price and evaluate options such as a reverse stock split, while emphasizing that the notice does not currently impact its business operations or SEC reporting obligations but could ultimately lead to delisting if compliance is not restored.
The most recent analyst rating on (LMFA) stock is a Hold with a $0.55 price target. To see the full list of analyst forecasts on LM Funding America stock, see the LMFA Stock Forecast page.
On January 6, 2026, LM Funding America, Inc. notified holders of outstanding common stock warrants to purchase 16,670,623 shares that the exercise price on these securities had been adjusted. The company reduced the warrant exercise price from $0.97 to $0.48 per share pursuant to the price protection provisions embedded in the warrants, following an offering referenced in a December 22, 2025 filing, a move that makes exercising the warrants more attractive and could lead to increased share issuance and potential dilution for existing shareholders.
The most recent analyst rating on (LMFA) stock is a Hold with a $0.57 price target. To see the full list of analyst forecasts on LM Funding America stock, see the LMFA Stock Forecast page.
On December 19, 2025, LM Funding America entered into securities purchase agreements with institutional investors for a registered direct offering of 1,822,535 common shares, 7,332,395 pre-funded warrants and 9,154,930 common warrants at a combined effective price of $0.71 per share or pre-funded warrant plus accompanying warrant, with the transaction closing on December 22, 2025 and generating approximately $6.0–$6.5 million in gross proceeds before fees. The company intends to use the net proceeds to expand its Bitcoin treasury strategy and for general corporate purposes, while agreeing to short-term restrictions on additional equity issuance, repricing and extending the term of 3,472,740 outstanding warrants held by an RDO investor, and compensating Maxim Group LLC as sole placement agent, moves that collectively bolster LM Funding’s capital base but also increase potential future share dilution for existing shareholders.
The most recent analyst rating on (LMFA) stock is a Hold with a $0.57 price target. To see the full list of analyst forecasts on LM Funding America stock, see the LMFA Stock Forecast page.
On November 7, 2025, LM Funding America, Inc. announced a reduction in the exercise price of its August 2025 Warrants to $0.97 per share, increasing the total shares issuable to 15,516,850. This adjustment also affected warrants from the October 2021 public offering, reducing their exercise price to $0.97 per share, reflecting anti-dilution provisions.
The most recent analyst rating on (LMFA) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on LM Funding America stock, see the LMFA Stock Forecast page.
On November 3, 2025, LM Funding America, Inc. announced a share repurchase program authorized by its Board of Directors, allowing the company to buy back up to $1.5 million of its common stock. The repurchases will be conducted through various methods, including open market purchases and privately negotiated transactions, and are subject to market conditions and legal requirements. The program, which may be funded by existing cash and credit facilities, is set to expire on September 30, 2026, but can be modified or discontinued at the Board’s discretion.
The most recent analyst rating on (LMFA) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on LM Funding America stock, see the LMFA Stock Forecast page.
On October 14, 2025, LM Funding America, Inc. held its annual meeting of stockholders, where three proposals were voted on. The election of directors resulted in the appointment of three Class III directors, while the appointment of MaloneBailey, LLP as the independent auditor for 2025 was ratified. Additionally, the issuance of more than 19.99% of the company’s outstanding common stock was approved, following two financing transactions in August 2025.
The most recent analyst rating on (LMFA) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on LM Funding America stock, see the LMFA Stock Forecast page.